Live Breaking News & Updates on Department Of Gastrointestinal Oncology

Stay updated with breaking news from Department of gastrointestinal oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr Shitara on the Background of the CheckMate 649 Trial in GEJ Adenocarcinoma

Kohei Shitara, MD, discusses the background of the phase 3 CheckMate 649 study in advanced gastric cancer, GEJ cancer, and esophageal adenocarcinoma. ....

Kohei Shitara , National Cancer Center Hospital , Department Of Gastrointestinal Oncology , Gastrointestinal Oncology , National Cancer Center Hospital East , Clinical Oncology ,

Japan's MHLW Approves Zolbetuximab in CLDN18.2-Positive Gastric Cancer

The Japanese Ministry of Health, Labour and Welfare has approved zolbetuximab for CLDN18.2-positive, unresectable, advanced or recurrent gastric cancer. ....

Kohei Shitara , Moitreyee Chatterjee Kishore , Japan Ministry Of Health , Astellas Pharma Inc , Department Of Gastrointestinal Oncology , National Cancer Center Hospital , Oncology Development At Astellas , Gastrointestinal Oncology , National Cancer Center Hospital East , Roche Diagnostics , Rxdx Assay , Immuno Oncology Development ,

Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3

Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Matt Scalo , Takayuki Yoshino , Dale Muzzey , Glenn Farrell , Department Of Gastrointestinal Oncology , Division For The Promotion Of Drug , Genetics Inc , Exchange Commission , National Cancer Center Hospital East , Deputy Director , Hospital East , Diagnostic Development , Gastrointestinal Oncology , Chief Scientific Officer , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports ,

Elevation Oncology Expands Ongoing Phase 1 Clinical Trial of EO-3021 Globally, Dosing First Patient in Japan

/PRNewswire/ Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies. ....

United States , Kohei Shitara , Valerie Malyvanh Jansen , National Cancer Center Hospital , Department Of Gastrointestinal Oncology , Prnewswire Elevation Oncology Inc , Corporate Communications Investor Relations , Elevation Oncology Inc , Exchange Commission , Chief Medical Officer , Gastrointestinal Oncology , National Cancer Center Hospital East , Elevation Oncology , Private Securities Litigation Reform Act , Oncology Investor , Corporate Communications , Health Care Amp Hospitals , Medical Pharmaceuticals , Clinical Trials Amp Medical Discoveries ,

Elevation Oncology (ELEV) Expands Ongoing Phase 1 Clinical Trial of EO-3021

Elevation Oncology (ELEV) Expands Ongoing Phase 1 Clinical Trial of EO-3021
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Valerie Malyvanh Jansen , Kohei Shitara , Elevation Oncology Inc , Department Of Gastrointestinal Oncology , National Cancer Center Hospital , Elevation Oncology , Malyvanh Jansen , Chief Medical Officer , Gastrointestinal Oncology , National Cancer Center Hospital East ,